Skip to main content
Full access
Articles
Published Online: 16 April 2018

Prevalence and Correlates of Prescription Stimulant Use, Misuse, Use Disorders, and Motivations for Misuse Among Adults in the United States

This article has been corrected.
VIEW CORRECTION

Abstract

Objective:

The authors sought to simultaneously examine the prevalence and correlates of prescription stimulant use, misuse, use disorders, and motivations for misuse in the U.S. adult population.

Method:

This was a nationally representative household population study of adults age 18 or older from the 2015 and 2016 National Surveys on Drug Use and Health (N=102,000). Measurements included prescription stimulant use, use without misuse, misuse without use disorders, and misuse with use disorders, as well as sociodemographic characteristics, health conditions, and mental health factors.

Results:

Among U.S. adults, 6.6% (annual average) used prescription stimulants overall; 4.5% used without misuse, 1.9% misused without use disorders, and 0.2% had use disorders. Adults with past-year prescription stimulant use disorders did not differ from those with misuse without use disorders in any of the examined sociodemographic characteristics and in many of the examined substance use problems. The most commonly reported motivations for misuse were to help be alert or concentrate (56.3%). The most likely source of misused prescription stimulants was by obtaining them free from friends or relatives (56.9%). More frequent prescription stimulant misuse and use disorder were associated with an increased likelihood of obtaining medications from physicians or from drug dealers or strangers and less likelihood of obtaining them from friends or relatives.

Conclusions:

Approximately 16.0 million U.S. adults used prescription stimulants in the preceding year (annual average), 5.0 million misused prescription stimulants, and 0.4 million had use disorders. Cognitive enhancement was the most commonly reported reason for misusing prescription stimulants. Patients who are using their medication for cognitive enhancement or diverting their medication to others present a high risk.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 741 - 755
PubMed: 29656665

History

Received: 26 September 2017
Revision received: 3 January 2018
Revision received: 13 February 2018
Accepted: 23 February 2018
Published online: 16 April 2018
Published in print: August 01, 2018

Keywords

  1. CNS Stimulants
  2. Epidemiology
  3. Psychoactive Substance Use Disorder

Authors

Details

Wilson M. Compton, M.D., M.P.E. [email protected]
From the National Institute on Drug Abuse, Bethesda, Md.; and the Substance Abuse and Mental Health Services Administration, Rockville, Md.
Beth Han, M.D., Ph.D.
From the National Institute on Drug Abuse, Bethesda, Md.; and the Substance Abuse and Mental Health Services Administration, Rockville, Md.
Carlos Blanco, M.D., Ph.D.
From the National Institute on Drug Abuse, Bethesda, Md.; and the Substance Abuse and Mental Health Services Administration, Rockville, Md.
Kimberly Johnson, Ph.D.
From the National Institute on Drug Abuse, Bethesda, Md.; and the Substance Abuse and Mental Health Services Administration, Rockville, Md.
Christopher M. Jones, Pharm.D., M.P.H.
From the National Institute on Drug Abuse, Bethesda, Md.; and the Substance Abuse and Mental Health Services Administration, Rockville, Md.

Notes

Address correspondence to Dr. Compton ([email protected]).

Competing Interests

Dr. Compton owns stock in 3M, General Electric, and Pfizer. Dr. Blanco owns stock in Eli Lilly, General Electric, and Sanofi. The other authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share